---
schema_version: "secwatch.filing_event.v1"
accession: "0001534969-26-000035"
form_type: "8-K"
ticker: "SERA"
cik: "0001534969"
company_name: "SERA PROGNOSTICS, INC."
filed_at: "2026-06-30T20:09:46+00:00"
generated_at: "2026-06-30T20:11:14.314225+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Sera Prognostics appoints Mark Capone to Board of Directors effective July 1, 2026

## Summary
- Mark Capone appointed as Class II director effective July 1, 2026, and to the Compensation Committee.
- Capone is former CEO of Myriad Genetics with 40+ years in diagnostics and life sciences.
- Initial equity award of $167,072 (or 150,000 option equivalents) granted July 10, 2026, with multi-year vesting.
- Annual equity awards of $88,359 (or 75,000 option equivalents) after each annual meeting, vesting over one year.
- Board determined Capone is independent under Nasdaq rules.

## SEC filing metadata
- accession: 0001534969-26-000035
- form_type: 8-K
- ticker: SERA
- cik: 0001534969
- company_name: SERA PROGNOSTICS, INC.
- filed_at: 2026-06-30T20:09:46+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534969/000153496926000035/0001534969-26-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534969/000153496926000035/sera-20260625.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001534969-26-000035
- JSON: https://secwatch.observer/filing/0001534969-26-000035.json
- Plain text: https://secwatch.observer/filing/0001534969-26-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.